{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:38:29Z","timestamp":1789508309516,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Today\u2019s world is characterized by increasing population density, human mobility, urbanization, and climate and ecological change. This global dynamic has various effects, including the increased appearance of emerging infectious diseases (EIDs), which pose a growing threat to global health security.<\/jats:p><jats:p>Outbreaks of EIDs, like the 2013\u20132016 Ebola outbreak in West Africa or the current Ebola outbreak in Democratic Republic of the Congo (DRC), have not only put populations in low- and middle-income countries (LMIC) at risk in terms of morbidity and mortality, but they also have had a significant impact on economic growth in affected regions and beyond.<\/jats:p><jats:p>The Coalition for Epidemic Preparedness Innovation (CEPI) is an innovative global partnership between public, private, philanthropic, and civil society organizations that was launched as the result of a consensus that a coordinated, international, and intergovernmental plan was needed to develop and deploy new vaccines to prevent future epidemics.<\/jats:p><jats:p>CEPI is focusing on supporting candidate vaccines against the World Health Organization (WHO) Blueprint priority pathogens MERS-CoV, Nipah virus, Lassa fever virus, and Rift Valley fever virus, as well as Chikungunya virus, which is on the WHO watch list. The current vaccine portfolio contains a wide variety of technologies, ranging across recombinant viral vectors, nucleic acids, and recombinant proteins. To support and accelerate vaccine development, CEPI will also support science projects related to the development of biological standards and assays, animal models, epidemiological studies, and diagnostics, as well as build capacities for future clinical trials in risk-prone contexts.<\/jats:p>","DOI":"10.1007\/s00103-019-03061-2","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T12:03:49Z","timestamp":1574856229000},"page":"65-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Developing vaccines against epidemic-prone emerging infectious diseases","Entwicklung von Impfstoffen gegen neu auftretende Infektionskrankheiten mit epidemischem Potenzial"],"prefix":"10.1007","volume":"63","author":[{"given":"Valentina","family":"Bernasconi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal G\u00f3mez","family":"Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Bettis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon Abebe","family":"Yimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Gurry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svein R.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Yeskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henshaw","family":"Mandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob P.","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Arne","family":"R\u00f8ttingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hatchett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Saville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnstein","family":"Norheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"key":"3061_CR1","first-page":"175","volume":"29","author":"N Vignier","year":"2018","unstructured":"Vignier\u00a0N, Bouchaud\u00a0O (2018) Travel, migration and emerging infectious diseases. EJIFCC 29:175\u2013179","journal-title":"EJIFCC"},{"key":"3061_CR2","volume-title":"The \u201cShattuck Flu Map\u201d, Institute for Disease Modeling","author":"H Hu","year":"2018","unstructured":"Hu\u00a0H, Ressler\u00a0B (2018) The \u201cShattuck Flu Map\u201d, Institute for Disease Modeling. http:\/\/www.idmod.org\/node\/295. Accessed 28 August 2019"},{"key":"3061_CR3","volume-title":"Commission on a global health risk framework for the future","author":"P Sands","year":"2016","unstructured":"Sands\u00a0P, Tomori\u00a0O, Aguilera\u00a0X et\u00a0al (2016) Commission on a global health risk framework for the future. http:\/\/www8.nationalacademies.org\/onpinews\/newsitem.aspx?RecordID=21891. Accessed 28 August 2019"},{"key":"3061_CR4","series-title":"Finance & Development","volume-title":"Epidemics and economics","author":"E David","year":"2018","unstructured":"David\u00a0E, Bloom\u00a0DC, Sevilla\u00a0JP (2018) Epidemics and economics. Finance & Development, vol 55"},{"key":"3061_CR5","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.3201\/eid1011.040729","volume":"10","author":"DM Bell","year":"2004","unstructured":"Bell\u00a0DM, World Health Organization Working Group on Prevention of International and Community Transmission of SARS (2004) Public health interventions and SARS spread, 2003. Emerg Infect Dis 10:1900\u20131906","journal-title":"Emerg Infect Dis"},{"key":"3061_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4103\/0970-2113.76299","volume":"28","author":"GL Dandagi","year":"2011","unstructured":"Dandagi\u00a0GL, Byahatti\u00a0SM (2011) An insight into the swine-influenza A (H1N1) virus infection in humans. Lung India 28:34\u201338","journal-title":"Lung India"},{"key":"3061_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12879-016-2137-3","volume":"17","author":"FS Aleanizy","year":"2017","unstructured":"Aleanizy\u00a0FS, Mohmed\u00a0N, Alqahtani\u00a0FY, El Hadi Mohamed\u00a0RA (2017) Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a\u00a0retrospective study. BMC Infect Dis 17:23","journal-title":"BMC Infect Dis"},{"key":"3061_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12992-016-0194-4","volume":"12","author":"J Kaner","year":"2016","unstructured":"Kaner\u00a0J, Schaack\u00a0S (2016) Understanding Ebola: the 2014 epidemic. Global Health 12:53","journal-title":"Global Health"},{"key":"3061_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4274\/jtgga.2017.0072","volume":"19","author":"AM Pereira","year":"2018","unstructured":"Pereira\u00a0AM, Monteiro\u00a0DLM, Werner\u00a0H et\u00a0al (2018) Zika virus and pregnancy in Brazil: what happened? J\u00a0Turk Ger Gynecol Assoc 19:39\u201347","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"3061_CR10","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1080\/21645515.2017.1412024","volume":"14","author":"G Wong","year":"2018","unstructured":"Wong\u00a0G, Qiu\u00a0X (2018) Funding vaccines for emerging infectious diseases. Hum Vaccin Immunother 14:1760\u20131762","journal-title":"Hum Vaccin Immunother"},{"key":"3061_CR11","doi-asserted-by":"publisher","first-page":"5846","DOI":"10.1016\/j.vaccine.2011.06.051","volume":"29","author":"ES Pronker","year":"2011","unstructured":"Pronker\u00a0ES, Weenen\u00a0TC, Commandeur\u00a0HR, Osterhaus\u00a0AD, Claassen\u00a0HJ (2011) The gold industry standard for risk and cost of drug and vaccine development revisited. Vaccine 29:5846\u20135849","journal-title":"Vaccine"},{"key":"3061_CR12","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1073\/pnas.1704507114","volume":"114","author":"WA Orenstein","year":"2017","unstructured":"Orenstein\u00a0WA, Ahmed\u00a0R (2017) Simply put: vaccination saves lives. Proc Natl Acad Sci U S\u00a0A 114:4031\u20134033","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3061_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1155\/1998\/390190","volume":"9","author":"RC Brunham","year":"1998","unstructured":"Brunham\u00a0RC, Coombs\u00a0KM (1998) In celebration of the 200th anniversary of Edward Jenner\u2019s Inquiry into the causes and effects of the variolae vaccinae. Can J Infect Dis 9:310\u2013313","journal-title":"Can J Infect Dis"},{"key":"3061_CR14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMp1613577","volume":"376","author":"JA Rottingen","year":"2017","unstructured":"Rottingen\u00a0JA, Gouglas\u00a0D, Feinberg\u00a0M et\u00a0al (2017) New vaccines against epidemic infectious diseases. N\u00a0Engl J Med 376:610\u2013613","journal-title":"N Engl J Med"},{"key":"3061_CR15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1099\/jmm.0.039180-0","volume":"61","author":"P Oyston","year":"2012","unstructured":"Oyston\u00a0P, Robinson\u00a0K (2012) The current challenges for vaccine development. J\u00a0Med Microbiol 61:889\u2013894","journal-title":"J Med Microbiol"},{"key":"3061_CR16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4103\/ijd.IJD_379_17","volume":"62","author":"S Mukherjee","year":"2017","unstructured":"Mukherjee\u00a0S (2017) Emerging infectious diseases: epidemiological perspective. Indian J Dermatol 62:459\u2013467","journal-title":"Indian J Dermatol"},{"key":"3061_CR17","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1016\/j.vaccine.2017.06.003","volume":"35","author":"S Plotkin","year":"2017","unstructured":"Plotkin\u00a0S, Robinson\u00a0JM, Cunningham\u00a0G, Iqbal\u00a0R, Larsen\u00a0S (2017) The complexity and cost of vaccine manufacturing\u2014an overview. Vaccine 35:4064\u20134071","journal-title":"Vaccine"},{"key":"3061_CR18","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.vaccine.2019.01.050","volume":"37","author":"G Drury","year":"2019","unstructured":"Drury\u00a0G, Jolliffe\u00a0S, Mukhopadhyay\u00a0TK (2019) Process mapping of vaccines: understanding the limitations in current response to emerging epidemic threats. Vaccine 37:2415\u20132421","journal-title":"Vaccine"},{"key":"3061_CR19","doi-asserted-by":"publisher","first-page":"S698","DOI":"10.1093\/infdis\/jiy175","volume":"218","author":"C Huber","year":"2018","unstructured":"Huber\u00a0C, Finelli\u00a0L, Stevens\u00a0W (2018) The economic and social burden of the 2014 Ebola outbreak in West Africa. J\u00a0Infect Dis 218:S698\u2013S704","journal-title":"J Infect Dis"},{"key":"3061_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1177\/2051013615611017","volume":"3","author":"S Sridhar","year":"2015","unstructured":"Sridhar\u00a0S (2015) Clinical development of Ebola vaccines. Ther Adv Vaccines 3:125\u2013138","journal-title":"Ther Adv Vaccines"},{"key":"3061_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/jlb\/lsw046","volume":"3","author":"EA Largent","year":"2016","unstructured":"Largent\u00a0EA (2016) EBOLA and FDA: reviewing the response to the 2014 outbreak, to find lessons for the future. J\u00a0Law Biosci 3:489\u2013537","journal-title":"J Law Biosci"},{"key":"3061_CR22","volume-title":"Coalition for Epidemic Preparedness Innovation (CEPI)","author":"Anonymous","year":"2019","unstructured":"Anonymous (2019) Coalition for Epidemic Preparedness Innovation (CEPI). http:\/\/www.cepi.net. Accessed 28 August 2019"},{"key":"3061_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3389\/fimmu.2019.00549","volume":"10","author":"DE Bloom","year":"2019","unstructured":"Bloom\u00a0DE, Cadarette\u00a0D (2019) Infectious disease threats in the twenty-first century: strengthening the global response. Front Immunol 10:549","journal-title":"Front Immunol"},{"key":"3061_CR24","volume-title":"List of blueprint priority diseases","author":"WHO","year":"2018","unstructured":"WHO (2018) List of blueprint priority diseases. https:\/\/www.who.int\/blueprint\/priority-diseases\/en\/. Accessed 28 August 2019"},{"key":"3061_CR25","volume-title":"More dangerous outbreaks are happening. Why aren\u2019t we worried about the next epidemic? In: Huffpost","author":"L Weber","year":"2018","unstructured":"Weber\u00a0L (2018) More dangerous outbreaks are happening. Why aren\u2019t we worried about the next epidemic? In: Huffpost. https:\/\/www.huffpost.com\/entry\/outbreaks-epidemic-preparedness. Accessed 28 August 2019"},{"key":"3061_CR26","doi-asserted-by":"publisher","first-page":"e399","DOI":"10.1016\/S1473-3099(19)30305-6","volume":"19","author":"R Hatchett","year":"2019","unstructured":"Hatchett\u00a0R, Lurie\u00a0N (2019) Outbreak response as an essential component of vaccine development. Lancet Infect Dis 19:e399\u2013e403","journal-title":"Lancet Infect Dis"},{"key":"3061_CR27","volume-title":"Safety, tolerability and immunogenicity of INO-4500 in healthy volunteers","author":"NIH","year":"2019","unstructured":"NIH (2019) Safety, tolerability and immunogenicity of INO-4500 in healthy volunteers. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03805984. Accessed 28 August 2019"},{"key":"3061_CR28","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1177\/0300985810372506","volume":"47","author":"PJ Snoy","year":"2010","unstructured":"Snoy\u00a0PJ (2010) Establishing efficacy of human products using animals: the US food and drug administration\u2019s \u201canimal rule\u201d. Vet Pathol 47:774\u2013778","journal-title":"Vet Pathol"},{"key":"3061_CR29","volume-title":"Product development under the animal rule, guidance for industry","author":"U.S. Department of Health and Human Services FaDA","year":"2015","unstructured":"U.S. Department of Health and Human Services FaDA, Center for Drug Evaluation and Research (Cder), Center for Biologics Evaluation and Research (Cber) (2015) Product development under the animal rule, guidance for industry"},{"key":"3061_CR30","unstructured":"Nc3rs (2019) https:\/\/nc3rs.org.uk\/. Accessed 28 August 2019"},{"key":"3061_CR31","volume-title":"WHO target product profile for Lassa virus vaccine","author":"WHO","year":"2017","unstructured":"WHO (2017) WHO target product profile for Lassa virus vaccine. https:\/\/www.who.int\/blueprint\/priority-diseases\/key-action\/LassaVirusVaccineTPP.PDF?ua=1. Accessed 28 August 2019"},{"key":"3061_CR32","volume-title":"WHO target product profiles for MERS-coV vaccines","author":"WHO","year":"2017","unstructured":"WHO (2017) WHO target product profiles for MERS-coV vaccines. https:\/\/www.who.int\/blueprint\/what\/research-development\/MERS_CoV_TPP_15052017.pdf?ua=1. Accessed 28 August 2019"},{"key":"3061_CR33","volume-title":"WHO target product profile for Nipah virus vaccine","author":"WHO","year":"2017","unstructured":"WHO (2017) WHO target product profile for Nipah virus vaccine. https:\/\/www.who.int\/blueprint\/priority-diseases\/key-action\/Nipah_virus_vaccineTPP.pdf?ua=1. Accessed 28 August 2019"},{"key":"3061_CR34","unstructured":"Brighton Collaboration (2019) https:\/\/www.brightoncollaboration.org\/. Accessed 28 August 2019"}],"updated-by":[{"DOI":"10.1007\/s00103-019-03085-8","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000}}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-019-03061-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-019-03061-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-019-03061-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T20:13:12Z","timestamp":1722111192000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-019-03061-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["3061"],"URL":"https:\/\/doi.org\/10.1007\/s00103-019-03061-2","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"assertion":[{"value":"27 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication of this article, the author name Richard Hatchett was incorrectly published.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication of this article, the author name Richard Hatchett was incorrectly published.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication of this article, the author name Richard Hatchett was incorrectly published.","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"V.\u00a0Bernasconi, P.A.\u00a0Kristiansen, M.\u00a0Whelan, R.G.\u00a0Rom\u00e1n, A.\u00a0Bettis, S.A.\u00a0Yimer, C.\u00a0Gurry, S.R.\u00a0Andersen, D.\u00a0Yeskey, H.\u00a0Mandi, A.\u00a0Kumar, J.\u00a0Holst, C.\u00a0Clark, J.P.\u00a0Cramer, J.-A.\u00a0R\u00f8ttingen, R.\u00a0Hatchett, M.\u00a0Saville, and G.\u00a0Norheim declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}